Dr. Anas Alomar

As a board-certified interventional cardiologist, Dr. Banerjee is internationally recognized for his expertise in minimally invasive treatments of coronary artery disease, peripheral artery disease and transcatheter aortic valve replacement. He is currently serving as the Paul J. Thomas Endowed Chair in Cardiology and chief of cardiovascular research and innovation for Baylor Scott & White Heart and Vascular Services-Dallas. Dr. Banerjee is the editor-in-chief of the American Journal of Cardiology, one of the premier cardiology journals in the world. He also serves as one of the founding directors of the Cardiovascular Innovations Foundation. He has led many landmark clinical trials, published over 450 peer-reviewed manuscripts, and is an invited faculty at national and international cardiovascular conferences. Dr. Banerjee is highly rated in 14 conditions, according to our data. His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Atherectomy, and Percutaneous Coronary Intervention (PCI).

Dr. Stoler is board-certified by the American Board of Internal Medicine in Interventional Cardiology. He is the Co-Medical Director of Cardiology and the Medical Director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital. He was appointed Clinical Professor of Medicine, Department of Internal Medicine at Texas A&M Health Science Center College of Medicine. He has published multiple cardiology-related articles in peer-reviewed medical journals and books, and he continues to be a principal investigator in many national clinical trials. After receiving his undergraduate and medical degree from Duke University, Dr. Stoler served his internship and residency in Internal Medicine at University of Texas Southwestern Medical Center in Dallas. He completed his fellowship in Cardiology and Interventional Cardiology at Beth Israel Hospital, Harvard Medical School in Boston. Dr. Stoler is recognized as a Fellow of the American College of Cardiology and The Society for Cardiovascular Angiography and Interventions. He is an active member of Dallas County Medical Society and Texas Medical Association. His professional interest and expertise lie in the various percutaneous treatments for coronary and structural heart disease. Publication. Dr. Stoler is highly rated in 15 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Coronary Heart Disease, Heart Attack, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Dr. Szerlip received her medical degree and completed her residency at Tulane University in New Orleans, Louisiana. She was a Major in the US Army where she was Vice Chief of the Internal Medicine Clinic at Eisenhower Army Medical Center in Augusta, Georgia. She completed her fellowship in cardiology at Medical College of Georgia and her interventional cardiology fellowship at William Beaumont Hospital in Royal Oak, Michigan. Dr. Szerlip joined the Baylor Scott and White Heart Hospital in Plano in 2013. She is the Medical Director of the Percutaneous Valve Program, which oversees both the large TAVR program as well as the percutaneous mitral and tricuspid programs. She helped start and grow the Structural Heart Fellowship Program in 2015 and in 2019 she helped develop and became the Program Director for the newly formed Cardiology Fellowship. She will also oversee the Interventional, EP and Heart failure sub-specialties. Prior to arriving at the Heart Hospital, she was faculty at the University of Arizona. Dr. Szerlip helped develop the structural heart program which was highlighted by the first percutaneous aortic valve program in Tucson. She was also Director of the Coronary Hybrid Revascularization program where she worked closely with the cardiothoracic surgeons in the combination of stenting the coronaries and robotic bypass. At the University of Arizona she developed her expertise in structural heart disease, which has led her to lecture nationally and internationally at major meetings and to become a rising figurehead in major studies pertaining to percutaneous valve treatments. In 2015, Dr. Szerlip was chosen by The Society for Cardiovascular Angiography and Interventions (SCAI) to participate in the Emerging Leader Mentorship (ELM) Program. As a member of this highly select group of physicians, Dr. Szerlip participated in a two-year mentorship program designed to further develop her skills as a leader in medicine, ambassador for her specialty, and advocate for her patients.  She is currently the Chairmen of SCAI publication committee and is a member of the SCAI Board of trustees. Her specialty and interests in interventional cardiology include structural heart disease, complex coronary disease and cardiogenic shock. Dr. Szerlip is highly rated in 18 conditions, according to our data. Her top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Heart Block, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).